Breast Cancer and Women's Health Bridging Prevention, Early Detection, and Unani Therapeutics in Integrative Oncology-A Review article.
DOI:
https://doi.org/10.63682/jns.v13i1.10425Keywords:
: Breast Cancer, Women's Health, Risk Factors, Early Detection, Unani Medicine, Herbal Therapeutics, Integrative Oncology, Prevention, Exercise, BRCA Mutations...Abstract
Breast cancer is the most frequently diagnosed cancer among women worldwide and remains a major public health challenge. It is a multifactorial disease influenced by genetic, hormonal, reproductive, lifestyle, and environmental factors. This review provides a comprehensive overview of breast cancer, including its epidemiology, classification, risk factors, clinical manifestations, prevention strategies, and current treatment approaches. Major risk factors such as advancing age, family history, BRCA1/BRCA2 gene mutations, obesity, alcohol consumption, early menarche, late menopause, and physical inactivity are discussed. Protective factors including regular physical activity, breastfeeding, multiparity, and healthy dietary habits are also highlighted. The review further examines conventional management strategies, including surgery, chemotherapy, radiotherapy, hormonal therapy, and targeted therapies. In addition, the potential role of Unani medicine and herbal therapeutics in integrative oncology is explored, with emphasis on medicinal plants such as Curcuma longa (Turmeric), Nigella sativa (Black Seed), Withania somnifera (Ashwagandha), and Camellia sinensis (Green Tea), which exhibit antioxidant, anti-inflammatory, immunomodulatory, and anticancer properties. The importance of early detection, regular screening, lifestyle modification, and multidisciplinary treatment approaches is emphasized. Integrating evidence-based traditional therapies with modern oncology may offer promising opportunities for improving patient outcomes, quality of life, and supportive care in breast cancer management
Downloads
References
[1] Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33
[2] Alkabban FM, Ferguson T. StatPearls; Treasure Island (FL): 2022. Breast Cancer.
[3] Abdelwahab Yousef AJ. Male Breast Cancer: Epidemiology and Risk Factors. Semin Oncol. 2017;44(4):267–72.
[4] Key TJ, Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol. 2013;14(10):1009–19
[5] Zeinomar N, Bandera EV, Qin B. Toward Understanding the Etiology of Male Breast Cancer: An Ongoing Research Challenge. JNCI Cancer Spectr. 2021;5(5)
[6] Lukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanislawek A. Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. Cancers (Basel). 2021;13(17)
[7] Benz CC. Impact of aging on the biology of breast cancer. Crit Rev Oncol Hematol. 2008;66(1):65–74.
[8] Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L, et al. Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 2018;5(2):77–106.
[9] McGuire A, Brown JA, Malone C, McLaughlin R, Kerin MJ. Effects of age on the detection and management of breast cancer. Cancers (Basel). 2015;7(2):908–29.
[10] 1Merrill RM, Sloan A. Risk-adjusted female breast cancer incidence rates in the United States. Cancer Epidemiol. 2012;36(2):137–40.
[11] White MC, Holman DM, Boehm JE, Peipins LA, Grossman M, Henley SJ. Age and cancer risk: a potentially modifiable relationship. Am J Prev Med. 2014;46(3) Suppl 1:S7–15.
[12] Davies KR, Cantor SB, Brewster AM. Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomy. Int J Womens Health. 2015;7:181–7
[13] Collaborative Group on Hormonal Factors in Breast C. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet. 2001;358(9291):1389–99.
[14] Mukama T, Risk of invasive breast cancer in relatives of patients with breast carcinoma in situ: a prospective cohort study. BMC Med. 2020;18(1):295.
[15] Kuchenbaecker KB, Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. JAMA. 2017;317(23):2402–16
[16] Meijers-Heijboer EJ, Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet. 2000;355(9220):2015–20.
[17] Ford D, Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998;62(3):676–89.
[18] van der Kolk DM, Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age. Breast Cancer Res Treat. 2010;124(3):643–51
[19] Baade P. Geographical Variation in Breast Cancer Outcomes. Int J Environ Res Public Health. 2017;14(5)
[20] Siegel RL, Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33
[21] Yedjou CG, Health and Racial Disparity in Breast Cancer. Adv Exp Med Biol. 2019;1152:31–49.
[22] Carey LA, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492–502.
[23] Eliassen AH, Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006;296(2):193–201.
[24] Lahmann PH, Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer. 2004;111(5):762–71.
[25] Fallone F, [Breast cancer, obesity and adipose tissue: a high-risk combination] Med Sci (Paris). 2018;34(12):1079–86.
[26] Morimoto LM, Obesity, body size, and risk of postmenopausal breast cancer: the Women’s Health Initiative (United States). Cancer Causes Control. 2002;13(8):741–51.
[27] Lee K, The Impact of Obesity on Breast Cancer Diagnosis and Treatment. Curr Oncol Rep. 2019;21(5):41
[28] Lauby-Secretan B,. Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med. 2016;375(8):794–8
[29] Neuhouser ML, Aragaki AK, Prentice RL, Manson JE, Chlebowski R, Carty CL, et al. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women’s Health Initiative Randomized Clinical Trials. JAMA Oncol. 2015;1(5):611–21.
[30] 30.Nelson HD, Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med. 2012;156(9):635–48.
[31] Green J, Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol. 2011;12(8):785–94
[32] Van den Brandt PA, Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000;152(6):514–27.
[33] Pizot C, Physical activity, hormone replacement therapy and breast cancer risk: A meta-analysis of prospective studies. Eur J Cancer. 2016;52:138–54.
[34] McTiernan A, Kooperberg C, White E, Wilcox S, Coates R, Adams-Campbell LL, et al. Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women’s Health Initiative Cohort Study. JAMA. 2003;290(10):1331–6.
[35] Boraka O, hysical Activity and Long-Term Risk of Breast Cancer, Associations with Time in Life and Body Composition in the Prospective Malmo Diet and Cancer Study. Cancers (Basel). 2022;14(8)
[36] Irwin ML, Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship study. Cancer Epidemiol Biomarkers Prev. 2009;18(1):306–13
[37] Prentice RL, Low-fat dietary pattern and risk of invasive breast cancer: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295(6):629–42.
[38] Jung S, Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst. 2013;105(3):219–36.
[39] Du M, Liu SH, Mitchell C, Fung TT. Associations between Diet Quality Scores and Risk of Postmenopausal Estrogen Receptor-Negative Breast Cancer: A Systematic Review. J Nutr. 2018;148(1):100–8.
[40] Van den Brandt PA, Schulpen M. Mediterranean diet adherence and risk of postmenopausal breast cancer: results of a cohort study and meta-analysis. Int J Cancer. 2017;140(10):2220–31.
[41] Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, et al. Light alcohol drinking and cancer: a meta-analysis. Ann Oncol. 2013;24(2):301–8.
[42] Chen WY, Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA. 2011;306(17):1884–90.
[43] Zhang SM, Alcohol consumption and breast cancer risk in the Women’s Health Study. Am J Epidemiol. 2007;165(6):667–76..
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
